Security key
36151G709
INTELLIGENT BIO SOLUTIONS INC. - COM NEW (INBS)
CUSIP: 36151G709
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 208,355
- Total 13F value
- $696,947
- Share change
- +192,928
- SEC-reported price per share
- $3.34
- Number of holders
- 9
- Value change
- +$644,453
- Number of buys
- 4
- Number of sells
- 6
Report period
Q1 2026
Institutions
9
Top holders
9
INBS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
INTELLIGENT BIO SOLUTIONS INC. SEC filings
INTELLIGENT BIO SOLUTIONS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36151G709
Recent filing periods:
Ownership snapshot
Top reported holders of INBS - INTELLIGENT BIO SOLUTIONS INC. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Life Science Biosensor Di...
Comparable rows
3/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
12 rows are not safely comparable across share classes.
13D/G row: Alyeska Investment Group, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 10%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership
Top 3
Alyeska Investment Group, L.P.
10%
ARMISTICE CAPITAL, LLC
10%
BIGGER CAPITAL FUND L P
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. |
13D/G
|
10%
|
—
944,310 shares
|
$0 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
|
—
163,571 shares
|
$0 | 31 Mar 2026 |
| BIGGER CAPITAL FUND L P |
13D/G
Bigger Michael
|
5%
|
$50,000
303,032 shares
|
$0 | 31 Dec 2024 |
| Life Science Biosensor Diagnostics Pty Ltd |
3/4/5
Former 10% owner
|
—
class O/S missing
|
$2,001,337
1,081,804 shares
|
— | 17 Feb 2022 |
| Ma-Ran Foundation |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$394,540
213,265 shares
|
— | 12 May 2023 |
| Gary W. Rollins Foundation |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$352,405
190,489 shares
|
— | 12 May 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
208,355
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
7
Q1 2026 holders
9
Holder diff
2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend